Stay updated on CARDINAL Trial: Bardoxolone Methyl in Alport Syndrome
Sign up to get notified when there's something new on the CARDINAL Trial: Bardoxolone Methyl in Alport Syndrome page.

Latest updates to the CARDINAL Trial: Bardoxolone Methyl in Alport Syndrome page
- Check4 days agoChange DetectedRevision: v3.3.3 was added to the history. HHS Vulnerability Disclosure and Revision: v3.3.2 were removed.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedAdded revision v3.3.2 and removed revision v3.2.0 from the Study Record History; this update reflects administrative version control rather than substantive changes to the trial data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check39 days agoChange DetectedThe government funding/operating status banner was removed from the page. This change does not affect the study records or their presentation.SummaryDifference0.5%

- Check53 days agoChange DetectedThe two screenshots depict the same page content with only minor layout/visual adjustments; no study data or version history details appear to change. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check82 days agoChange DetectedMajor change: version updated to v3.2.0 with a government-operating-status notice; previous version v3.1.0 removed. Interpreted as an update to page status and versioning.SummaryDifference10%

- Check89 days agoChange DetectedThe page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag, signaling a software version upgrade.SummaryDifference0.2%

Stay in the know with updates to CARDINAL Trial: Bardoxolone Methyl in Alport Syndrome
Enter your email address, and we'll notify you when there's something new on the CARDINAL Trial: Bardoxolone Methyl in Alport Syndrome page.